Long‐term parental distress after pediatric hematopoietic stem cell transplantation for nonmalignant diseases
Pediatric Blood & Cancer · 2023-11 · 70 (11)
DOI: 10.1002/pbc.30638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 28.08.2023. Verfasst von Joëll E Bense und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Stem Cell Transplantation, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The …. Hauptthemen laut MEDLINE: Parents, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Survival rates have continued to increase for pediatric hematopoietic stem cell transplantation (HSCT) for nonmalignant diseases. Despite the crucial role of caregivers in this high‐intensity treatment, knowledge about long‐term parental impact is lacking. Procedure This cross‐sectional study assessed parental distress and everyday problems in parents of patients 2 years and older after pediatric HSCT for a nonmalignant disease using Distress Thermometer for Parents (DT‐P), and compared outcomes to matched Dutch parents of healthy children and Dutch parents of children with a chronic condition (CC).
Results
Median follow‐up was 5.3 years (interquartile range [IQR]: 2.9–8.6). Underlying diseases were inborn errors of immunity ( N = 30), hemoglobinopathies ( N = 13), and bone marrow failure ( N = 27). Mothers of pediatric HSCT recipients ( N = 70) reported comparable overall distress levels to mothers of healthy children, but experienced more distress related to parenting problems, specifically managing their child's emotions, discussing disease consequences, and fostering independence. Fathers of HSCT recipients ( N = 45) reported higher overall distress levels and had more emotional distress compared to fathers of healthy children.
Conclusions
Overall, parental distress and everyday problems of parents of HSCT recipients are comparable to those of parents of children with CC. However, there is ongoing parental burden, both emotional and in parenting, long‐term after HSCT compared to parents of healthy children, and the type of burden differs between mothers and fathers. These results indicate that individualized parental supportive care should not remain restricted to the acute hospitalization phase, but also be actively offered during long‐term follow‐up after pediatric HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Stem Cell Transplantation, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
- Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Leiden, The Netherlands.
ORCID-Profile: Joëll E Bense
Zitieren
APA
Bense, J. E., Stiggelbout, A. M., Lankester, A. C., & de Pagter, A. P. J. (2023). Long‐term parental distress after pediatric hematopoietic stem cell transplantation for nonmalignant diseases. Pediatric Blood & Cancer, 70(11). https://doi.org/10.1002/pbc.30638
Vancouver
Bense JE, Stiggelbout AM, Lankester AC, de Pagter APJ. Long‐term parental distress after pediatric hematopoietic stem cell transplantation for nonmalignant diseases. Pediatric Blood & Cancer. 2023;70(11). doi:10.1002/pbc.30638
BibTeX
@article{Bense2023,
author = {Bense, Joëll E and Stiggelbout, Anne M and Lankester, Arjan C and de Pagter, Anne P J},
title = {Long‐term parental distress after pediatric hematopoietic stem cell transplantation for nonmalignant diseases},
journal = {Pediatric Blood & Cancer},
year = {2023},
volume = {70},
number = {11},
doi = {10.1002/pbc.30638}
}
EUVIMED